Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular remission in high-risk chronic lymphocytic leukaemia.
Carol D
CD
Jones
Sally
S
Arai
Robert
R
Lowsky
Dolly B
DB
Tyan
James L
JL
Zehnder
David B
DB
Miklos
D006085:Graft Survival / Q000276:immunology*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy*; D018365:Neoplasm, Residual; D011379:Prognosis; D012074:Remission Induction; D013601:T-Lymphocytes / Q000473:pathology*; D019172:Transplantation Conditioning / Q000379:methods